These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 125108)

  • 21. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen, produced by plasmin (fragments X).
    Nieuwenhuizen W; Gravesen M
    Biochim Biophys Acta; 1981 Mar; 668(1):81-8. PubMed ID: 6453618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of divalent cations in the plasmin degradation of fibrinogen.
    Dang CV; Bell WR; Ebert RF; Starksen NF
    Arch Biochem Biophys; 1985 May; 238(2):452-7. PubMed ID: 3158281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of segments essential for polymerization and for calcium binding in the gamma-chain of human fibrinogen.
    Váradi A; Scheraga HA
    Biochemistry; 1986 Feb; 25(3):519-28. PubMed ID: 2937452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of high molecular weight plasmic degradation products of human crosslinked fibrin.
    Olexa SA; Budzynski AZ; Marder VJ
    Biochim Biophys Acta; 1979 Jan; 576(1):39-50. PubMed ID: 153766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic identification of the cleavage products from the A alpha- and B beta-chains in the early stages of plasmin digestion of fibrinogen.
    Liu CY; Sobel JH; Weitz JI; Kaplan KL; Nossel HL
    Thromb Haemost; 1986 Aug; 56(1):100-6. PubMed ID: 2946092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The alpha(E)C domain of human fibrinogen-420 is a stable and early plasmin cleavage product.
    Applegate D; Steben LS; Hertzberg KM; Grieninger G
    Blood; 2000 Apr; 95(7):2297-303. PubMed ID: 10733499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble high-molecular-weight E fragments in the plasmin-induced degradation products of cross-linked human fibrin.
    Gaffney PJ; Lane DA; Brasher M
    Clin Sci Mol Med; 1975 Aug; 49(2):149-56. PubMed ID: 125178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
    Cierniewski CS; Kloczewiak M; Budzynski AZ
    J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A unique proteolytic fragment of human fibrinogen containing the A alpha COOH-terminal domain of the native molecule.
    Kirschbaum NE; Budzynski AZ
    J Biol Chem; 1990 Aug; 265(23):13669-76. PubMed ID: 2143188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator.
    Nieuwenhuizen W; Vermond A; Voskuilen M; Traas DW; Verheijen JH
    Biochim Biophys Acta; 1983 Oct; 748(1):86-92. PubMed ID: 6684481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    J Biol Chem; 1979 Jun; 254(11):4925-32. PubMed ID: 155698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma and platelet fibrinogen differ in gamma chain content.
    Francis CW; Nachman RL; Marder VJ
    Thromb Haemost; 1984 Feb; 51(1):84-8. PubMed ID: 6719392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino acid sequence studies on the alpha chain of human fibrinogen. Covalent structure of the alpha-chain portion of fragment D.
    Doolittle RF; Cassman KG; Cottrell BA; Friezner SJ; Takagi T
    Biochemistry; 1977 Apr; 16(8):1710-5. PubMed ID: 139916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural difference between polymerized and non-polymerized fragment X, obtained by plasmin digest of fibrinogen.
    Sato H; Swadesh JK
    Int J Biol Macromol; 1993 Dec; 15(6):323-7. PubMed ID: 8110652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary structure of human fibrinogen and fibrin. Structural studies on NH2-terminal part of B beta chain.
    Hessel B; Makino M; Iwanaga S; Blombäck B
    Eur J Biochem; 1979 Aug; 98(2):521-34. PubMed ID: 158526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradation of human fibrinogen by plasmin: isolation and partial characterization of an early degradation product.
    Regañon E; Aznar J; Vila V
    Haemostasis; 1978; 7(1):26-34. PubMed ID: 147811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunochemical mapping of the conformation of human fibrinogen. The gamma 95-264 segment in inaccessible to antibody in native fibrinogen but progressively exposed by plasmic cleavage.
    Fair DS; Edgington TS; Plow EF
    J Biol Chem; 1981 Aug; 256(15):8018-23. PubMed ID: 6167572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of fragment E species from human cross-linked fibrin.
    Olexa SA; Budzynski AZ; Doolittle RF; Cottrell BA; Greene TC
    Biochemistry; 1981 Oct; 20(21):6139-45. PubMed ID: 6458323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence.
    Dang CV; Ebert RF; Bell WR
    J Biol Chem; 1985 Aug; 260(17):9713-9. PubMed ID: 3160702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.